Lisa Coussens, Ph.D.

Dr. Coussens is the Chair of the Department of Cell, Developmental & Cancer Biology, and Deputy Director for Basic & Translational Research in the Knight Cancer Institute at Oregon Health & Sciences University (OHSU) and holds the Hildegard Lamfrom Chair in Basic Science. Dr. Coussens research focus is on elucidating the roles of immune cells and their mediators as critical regulators of solid tumor development. Her lab reported that lymphocytes selectively regulate myeloid cell functions in mouse models of squamous and mammary carcinoma, mesothelioma, and pancreatic adenocarcinoma, and that selective inhibition of key factors regulating either myeloid recruitment or function significantly enhances efficacy of chemo- and radiation therapy, and thereby extend long term survival of tumor-bearing mice. These discoveries are currently being translated into the clinical realm. Dr. Coussens was awarded a Stand Up to Cancer – Lustgarten Foundation Pancreatic Cancer Convergence Dream Team Translational Research grant focused on clinical evaluation of immune-based therapies in pancreas cancer.

Dr. Coussens has received the prestigious Gertrude B. Elion Award from the American Association of Cancer Research (AACR), the Mallinckrodt Award for Medical Science, a V Foundation Scholar Award, and two sequential Era of Hope Scholar Awards from the Department of Defense Breast Cancer Research Program. In 2012, she was the recipient of the AACR-Women in Cancer Research Charlotte Friend Memorial Lectureship, and the 2015 recipient of the 13th Rosalind E. Franklin Award from the National Cancer Institute. She received her Ph.D. in Biological Chemistry from UCLA in 1993 and completed her postdoctoral fellowship in Cancer Biology at UCSF in Douglas Hanahans’ laboratory.